Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial : The Lancet Neurology

Links shared publicly online about this topic.

  • 1,123
    total visits

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial : The Lancet Neurology

thelancet.com —

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. By - Raju Kapoor FRCP, Julian Furby MRCP, Thomas H...

View full resource at thelancet.com

Tags: Neurology, Multiple Sclerosis, Seizure Medication, Lamictal, Epilepsy Medication

  • Share

Most Recently Shared on June 7, 2010 at 12:53 pm By:

MS_Wisdom2 OrganizedWisdom MS

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo .... http://bit.ly/dyIQlH

2 years ago...

Reply

Retweet

Favorite

Advertisement